Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476230 (US10874634, Cmpd No. 12 | US11364220, Compound 12) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476235 (US10874634, Cmpd No. 17 | US11364220, Compound 17) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476224 (US10874634, Cmpd No. 07 | US11364220, Compound 07) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 470 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476228 (US10874634, Cmpd No. 10 | US11364220, Compound 10) | UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476237 (US10874634, Cmpd No. 19 | US11364220, Compound 19) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 741 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476180 (US10874634, Cmpd No. 02 | US11364220, Compound 02) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 830 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476217 (US10874634, Cmpd No. 04 | US11364220, Compound 04) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 1.14E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476223 (US10874634, Cmpd No. 06 | US11364220, Compound 06) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 1.29E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476234 (US10874634, Cmpd No. 16 | US11364220, Compound 16) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.77E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476238 (US10874634, Cmpd No. 21 | US11364220, Compound 21) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476180 (US10874634, Cmpd No. 02 | US11364220, Compound 02) | UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 2.06E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476226 (US10874634, Cmpd No. 09 | US11364220, Compound 09) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476225 (US10874634, Cmpd No. 08 | US11364220, Compound 08) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 3.17E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476173 (US10874634, Cmpd No. 01 | US11364220, Compound 01) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 5.66E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476231 (US10874634, Cmpd No. 13 | US11364220, Compound 13) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476228 (US10874634, Cmpd No. 10 | US11364220, Compound 10) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 8.23E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476221 (US10874634, Cmpd No. 04B) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.24E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476173 (US10874634, Cmpd No. 01 | US11364220, Compound 01) | UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 8.81E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476236 (US10874634, Cmpd No. 18 | US11364220, Compound 18) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.07E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476222 (US10874634, Cmpd No. 05 | US11364220, Compound 05) | UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 1.15E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476234 (US10874634, Cmpd No. 16 | US11364220, Compound 16) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.19E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476218 (US10874634, Cmpd No. 04A) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476226 (US10874634, Cmpd No. 09 | US11364220, Compound 09) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.42E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476217 (US10874634, Cmpd No. 04 | US11364220, Compound 04) | UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 1.89E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476225 (US10874634, Cmpd No. 08 | US11364220, Compound 08) | UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 1.92E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476229 (US10874634, Cmpd No. 11) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476238 (US10874634, Cmpd No. 21 | US11364220, Compound 21) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.18E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476232 (US10874634, Cmpd No. 14 | US11364220, Compound 14) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.84E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476235 (US10874634, Cmpd No. 17 | US11364220, Compound 17) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.87E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476222 (US10874634, Cmpd No. 05 | US11364220, Compound 05) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 3.97E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476223 (US10874634, Cmpd No. 06 | US11364220, Compound 06) | UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 4.23E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476181 (US10874634, Cmpd No. 03 | US11364220, Compound 03) | UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 6.54E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476227 (US10874634, Cmpd No. 09A | US11364220, Compound 09...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476233 (US10874634, Cmpd No. 15 | US11364220, Compound 15) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476237 (US10874634, Cmpd No. 19 | US11364220, Compound 19) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476181 (US10874634, Cmpd No. 03 | US11364220, Compound 03) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476232 (US10874634, Cmpd No. 14 | US11364220, Compound 14) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476231 (US10874634, Cmpd No. 13 | US11364220, Compound 13) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476229 (US10874634, Cmpd No. 11) | UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476224 (US10874634, Cmpd No. 07 | US11364220, Compound 07) | UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476233 (US10874634, Cmpd No. 15 | US11364220, Compound 15) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26B1 (Homo sapiens (Human)) | BDBM476230 (US10874634, Cmpd No. 12 | US11364220, Compound 12) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cytochrome P450 26A1 (Homo sapiens (Human)) | BDBM476236 (US10874634, Cmpd No. 18 | US11364220, Compound 18) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
Queen''s University at Kingston US Patent | Assay Description CYP26A1 or CYP26B1 stably transfected HeLa cells were maintained in Minimum Essential Medium (MEM) containing 10% fetal bovine serum (FBS) and 100 ... | US Patent US10874634 (2020) BindingDB Entry DOI: 10.7270/Q2Q52SP3 | |||||||||||
More data for this Ligand-Target Pair |